Emerging from the Fog
Emerging from the Fog
Preparing Your Budget for Reopening
by Alacias Enger
Taylor is a forty-year-old New York City resident who, like many, is trying to successfully...
Getting to Zero Illinois Launches HIV Dashboard
Getting to Zero Illinois Launches HIV Dashboard
On August 18, 2021, Getting to Zero Illinois (GTZ-IL) held a virtual panel discussion to launch the state’s...
CDC Awards $117 Million to Advance Health Equity
CDC Awards $117 Million to Advance Health Equity
The Centers for Disease Control and Prevention (CDC) announced on July 27, 2021, that it has awarded...
PACHA Highlights
PACHA Highlights
A Wrap-Up of the 71st President’s Advisory Council on HIV and AIDS (PACHA) Meeting
by Hank Trout
On August 3 and 4, 2021, the President’s...
SYNChronicity 2021 Goes Virtual Again
SYNChronicity 2021 Goes Virtual Again
SYNChronicity 2021, the 8th Annual National HIV, HCV, STI, and LGBTQ Health Conference, will occur virtually again this year on...
Reaserching a Monthly Pill for PrEP for Cis Women
Researchers Receive $122 Million to Study Monthly Pill for PrEP
The University of Washington School of Medicine announced that it has received $122 million from...
Transgender Inclusion Is Needed in HIV National Strategic Plans
All Need Access
A New Report Promotes the Inclusion of Transgender Individuals in HIV National Strategic Plans
by Hank Trout
On June 7, 2021, amfAR, The Foundation...
Fundamentals in Focus
Fundamentals in Focus
The Building Blocks of a Secure Financial Future
by Alacias Eager
Danielle is a thirty-one-year-old Administrative Assistant and resident of Buffalo, New York. She...
COVID Disrupted HIV Testing—Now We Get Back on Track
Getting Back on Track
HIV Testing Rates Dropped During COVID
by Hank Trout
According to an April 21, 2021, report by NPR, rates of testing for HIV...
Make All Breastfeeding Great Again
Make All Breastfeeding Great Again
Reframing Infant Feeding for Women Living with HIV
by Claire Gasamagera
In the United States where there is access to clean water...
LATEST POSTS
Vaccine in Imbokodo Study Fails to Provide Protection
Phase 2b HIV Trial Vaccine Fails
Preliminary analysis of the Imbokodo study of an experimental HIV vaccine demonstrated that the vaccine did not provide sufficient...
